Trial intelligence / Profile preview

Topiramate for weight loss in Iranian patients with type 2 diabetes mellitus

IRCT201112036027N2Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Oct 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of topiramate in obesity and type 2 diabetes mellitus (T2DM), sponsored by Tehran University of Medical Sciences. Started Oct 2008; status: completed.

02

Drugs

topiramate
03

Conditions

obesitytype 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on IRCT201112036027N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201112036027N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call